🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be conducted to compare the pharmacokinetic (PK) exposure a...
Status
Completed
Location
Research Site
Start Date
2022-03-22
Trial ID
NCT05339100
Treatments Being Tested
This is a multicenter, randomized, open-label, parallel-group study designe...
Status
Completed
Location
Research Site
Start Date
2019-05-21
Trial ID
NCT03968978
Treatments Being Tested
This is a study to compare PK of tezepelumab exposure in healthy subjects b...
Status
Completed
Location
Research Site
Start Date
2019-06-19
Trial ID
NCT03989544
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of AZD2373 i...
Status
Recruiting
Location
Research Site
Start Date
2025-03-05
Trial ID
NCT06824987
Treatments Being Tested
A Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled...
Status
Completed
Location
Research Site
Start Date
2021-04-22
Trial ID
NCT04851964
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group, int...
Status
Terminated
Location
Research Site
Start Date
2019-11-25
Trial ID
NCT04157335
Treatments Being Tested
An open-label, single dose Pharmacokinetic (PK) comparability study to demo...
Status
Completed
Location
Research Site
Start Date
2017-01-04
Trial ID
NCT02968914
Treatments Being Tested
The purpose of the study is to assess functionality, performance, and relia...
Status
Completed
Location
Research Site
Start Date
2015-04-27
Trial ID
NCT02417961
Treatments Being Tested
The rationale of the roll-over study (ROSY) is to provide continuous access...
Status
Recruiting
Location
Research Site
Start Date
2026-07-24
Trial ID
NCT07444567
Treatments Being Tested
The purpose of this study is to characterize the pharmacokinetics (PK), pha...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-28
Trial ID
NCT07630714
Treatments Being Tested